Inhibitor effect of vaginal Lactobacilli on group B streptococci;Vajinal laktobasillerin grup B streptokoklar üzerinderki inhibitor etkinliǧi

Mikrobiyoloji Bulteni

Volumn 39, Issue 1, 2005, Pages 17-23

  Açikgöz, Ziya Cibali ^a   Gamberzade, Şöhret ^a   Göçer, Safiye ^a   Ceylan, Pakize ^a  

^a FATIH UNIVERSITY   (Turkey)

Author keywords

Group B streptococcus; Lactobacillus; Meningitis; Neonatal sepsis; Probiotic

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; FEMALE; HUMAN; LACTOBACILLUS; MICROBIOLOGY; PHYSIOLOGY; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VAGINA;

FEMALE; HUMANS; LACTOBACILLUS; PROBIOTICS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA;

EID: 33646935769     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bruce AW, Reid G: Intravaginal instillation of Lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol 1988, 34: 339-343.
2. Mclean NW, Rosenstein IJ: Characterization and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000, 49: 543-552.
3. Marchand J, Vandenplas Y. Microorganisms administered in the benefit of the host: Mythes and the facts. Eur J Gastroenterol Hepatol 2000, 12: 1077-1088.
4. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B: Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001, 30: 49-52.
5. Osset J, Bartolome RM, Garcia E: Assesment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. The J Inf Dis 2001, 183: 485-491.
6. Andreu A, Stapleton AE, Fennell CL: Hemagglutination, adherence, and surface properties of vaginal Lactobacillus species. J Infect Dis 1995, 171: 1237-1243.
7. Ohashi H, Kosakai N, Yamada T: Clinical and bacteriological study on microbiological flora in vagina. (4) The influence of lactobacilli on group B streptococcus. Kansenhakago Zasshi 1981, 209: 373-380.
8. Baron JE, Peterson LR, Finegold MS (eds): Genital and sexually transmitted pathogens, p. 263-264. Bailey and Scott's Diagnostic Microbiology. 1994, 9th ed. Mosby Year Book, Washington DC.
9. Schuhat A: Neonatal group B streptococcal disease-screening and prevention. N Eng J Med 2000, 343: 209-210.
10. Edwards MS, Baker CJ: Streptococcus agalactia (Group B Streptococcus), p. 1835-1845. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases. 1995, Churchill Livingstone, New York.
11. Schuchat A: Epidemiology of group B streptococcal diseases in the United States: Shifting paradigms. Clin Microbiol Rev 1998, 11: 497-510.
12. Reisner DP, Haas MJ, Rosalee WZ, Williams MA, Luthy DA: Performance of a group B streptococcal prophylaxis protocol combining high-risk treatment and low risk screening. Am J Obstet Gynecol 2000, 182: 1335-1343.
13. Main EK, Slagle T: Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: The superiority of culture-based protocols. Am J Obstet Gynecol 2000, 182: 1344-1355.
14. Alvarez-Olmes MI, Oberhelman RA: Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 2001, 32: 1567-1576.
15. Pessi T, Sutas Y, Hurme M, Isolauri F: Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000, 30: 1804-1808.
16. Song YL, Kato N, Matsumiya L, Liu CX, Kato H, Watanabe K: Identification of Lactobacillus species of human origin by a commercial kit, API 50CHL. Rinsho Biseibutshu Jinsohu Shinden Kenkyukai Shi 1999, 10: 77-82.